Taper Or Abrupt Steroid Stop: TOASSTtrial
Glucocorticoid Withdrawal and Glucocorticoid-induced Adrenal Insufficiency: a Randomized Controlled Multicenter Trial
Sponsor: Gebauer Stiftung Zurich
Listed as NCT03153527, this PHASE4 trial focuses on Autoimmune and Inflammatory Disorder and remains actively recruiting participants. Sponsored by Gebauer Stiftung Zurich, it has been updated 16 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
16 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE4
-
Sep 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Feb 2025 — Sep 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
▶ Show 11 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
Jun 2022 — Dec 2023 [monthly]
Recruiting PHASE4
-
Jun 2021 — Jun 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE4
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Aug 2019 — Aug 2020 [monthly]
Recruiting PHASE4
-
Feb 2019 — Aug 2019 [monthly]
Recruiting PHASE4
-
Nov 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Aug 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gebauer Stiftung Zurich
- HEMMI Stiftung Switzerland
- Kantonsspital Baselland Bruderholz
- Swiss National Science Foundation
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .